CARE reaffirms rating assigned to bank facilities of Cipla

22 Jan 2016 Evaluate

Credit rating agency, Credit Analysis and Research (CARE) has reaffirmed ‘AAA / A1+’ rating to the various bank facilities of Cipla for an aggregate amount of Rs 3,310.50 crore.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.


Cipla Share Price

1347.65 -10.15 (-0.75%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×